Stakeholders Split Over Proposed Changes To Prescription Drug Benefits

January 22, 2015 at 4:38 PM
Pharmaceutical, health insurance and state insurance and exchange officials have mixed reviews on CMS' proposal to replace drug count standards with a requirement that qualified health plans (QHPs) install pharmacy-and-therapeutics (P&T) committees in 2017 to ensure that formulary drug lists cover a sufficient number and type of prescription drugs. The drug and insurance industries generally support the idea, with some reservations, whilestate insurance regulators say CMS should scrap the P&T committee idea entirely. If the 2016 benefits and payment parameters...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.